seneca biopharma Archives - NeuroNews International

Seneca Biopharma announces phase II clinical study for treatment of ischaemic...

21 January 2021

Seneca Biopharma has announced its preliminary top-line results of the placebo-controlled phase II stroke study that was conducted in Beijing, China. According to a company...

Write to us
Editor: Jamie Bell [email protected]
Advertising: Michael Broughton [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: seneca biopharma

Seneca Biopharma announces phase II clinical study for treatment of ischaemic...